Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01182766 · ClinicalTrials.gov registry record · Phase 2
New Treatment for Alcohol and Nicotine Dependence
A Phase 2 study, sponsored by University of Virginia.
- Completed
- Registry status
- Phase 2
- Development phase
- 236
- Enrollment target
NCT01182766 is a Phase 2 study that has completed, run by University of Virginia. The registered enrollment target is 236 participants.
The verdict
NCT01182766, a Phase 2 study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 236 participants
- Enrollment target
Study Summary
This research study aims to test whether topiramate (a drug that is being used for seizure) will help individuals who have problems with both alcohol and nicotine. The investigators believe that individuals taking topiramate will be more successful at abstaining from both alcohol and nicotine than individuals taking placebo.
Interventions
- DRUG Placebo
- DRUG Low-Dose Topiramate
- DRUG High-Dose Topiramate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 236 participants |
| Start Date | 2011-11-01 |
| Est. Completion | 2017-10-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01182766
The ClinicalTrials.gov registry entry for NCT01182766 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 236 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Placebo is the first listed.
NCT01182766 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01182766 about?
NCT01182766 is a clinical study titled "New Treatment for Alcohol and Nicotine Dependence". This research study aims to test whether topiramate (a drug that is being used for seizure) will help individuals who have problems with both alcohol and nicotine. The investigators believe that individuals taking topiramate will be more successful at abstaining from both alcohol and nicotine than i...
What is the current status of trial NCT01182766?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 236 participants. The study started on 2011-11-01. Estimated completion is 2017-10-06.
What interventions are being tested in trial NCT01182766?
The interventions under investigation include: Placebo (DRUG), Low-Dose Topiramate (DRUG), High-Dose Topiramate (DRUG).
Who is sponsoring clinical trial NCT01182766?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.